Literature DB >> 8458403

Opposing actions of an adenosine A2 receptor agonist and a GTP analogue on the regulation of dopamine D2 receptors in rat neostriatal membranes.

S Ferré1, P Snaprud, K Fuxe.   

Abstract

We have previously found, in rat striatal membrane preparations, that stimulation of adenosine A2 receptors (with the selective adenosine A2 receptor agonist CGS 21680) increases the high- and low-affinity dissociation constants and increases the proportion of high-affinity dopamine D2 receptor binding sites labelled with the selective dopamine D2 receptor antagonist [3H]raclopride. As guanine nucleotides and divalent cations (such as Mg2+) are known to regulate the proportion of high-affinity D2 receptor binding sites in opposing ways, interaction experiments with CGS 21680, the GTP analogue Gpp(NH)p and MgCl2 were performed. Our results suggest that these three factors exert significant, though independent, effects on the proportion of high affinity D2 receptors, and that A2 receptors regulate both the affinity of D2 receptors and the transduction of the signal from the D2 receptor to the G-protein.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8458403     DOI: 10.1016/0922-4106(93)90157-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Receptor-receptor interactions as an integrative mechanism in nerve cells.

Authors:  M Zoli; L F Agnati; P B Hedlund; X M Li; S Ferré; K Fuxe
Journal:  Mol Neurobiol       Date:  1993 Fall-Winter       Impact factor: 5.590

2.  Adenosine A1 and A2A receptors are not upstream of caffeine's dopamine D2 receptor-dependent aversive effects and dopamine-independent rewarding effects.

Authors:  Jessica E Sturgess; Ryan A Ting-A-Kee; Dominik Podbielski; Laurie H L Sellings; Jiang-Fan Chen; Derek van der Kooy
Journal:  Eur J Neurosci       Date:  2010-06-22       Impact factor: 3.386

3.  Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum.

Authors:  S Ferré; R Schwarcz; X M Li; P Snaprud; S O Ogren; K Fuxe
Journal:  Psychopharmacology (Berl)       Date:  1994-11       Impact factor: 4.530

Review 4.  Astrocyte-neuron interaction in the dorsal striatum-pallidal circuits and alcohol-seeking behaviors.

Authors:  Sa-Ik Hong; Seungwoo Kang; Matthew Baker; Doo-Sup Choi
Journal:  Neuropharmacology       Date:  2021-08-22       Impact factor: 5.273

Review 5.  Purinergic Receptors in Basal Ganglia Diseases: Shared Molecular Mechanisms between Huntington's and Parkinson's Disease.

Authors:  Talita Glaser; Roberta Andrejew; Ágatha Oliveira-Giacomelli; Deidiane Elisa Ribeiro; Lucas Bonfim Marques; Qing Ye; Wen-Jing Ren; Alexey Semyanov; Peter Illes; Yong Tang; Henning Ulrich
Journal:  Neurosci Bull       Date:  2020-10-07       Impact factor: 5.203

6.  Inhibition by KF17837 of adenosine A2A receptor-mediated modulation of striatal GABA and ACh release.

Authors:  M Kurokawa; I P Kirk; K A Kirkpatrick; H Kase; P J Richardson
Journal:  Br J Pharmacol       Date:  1994-09       Impact factor: 8.739

Review 7.  Adenosine: a prototherapeutic concept in neurodegeneration.

Authors:  D K von Lubitz; M F Carter; M Beenhakker; R C Lin; K A Jacobson
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

Review 8.  Allosteric Interactions between Adenosine A2A and Dopamine D2 Receptors in Heteromeric Complexes: Biochemical and Pharmacological Characteristics, and Opportunities for PET Imaging.

Authors:  Kavya Prasad; Erik F J de Vries; Philip H Elsinga; Rudi A J O Dierckx; Aren van Waarde
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.